Identification of a genetic locus modulating splenomegaly induced by granulocyte colony-stimulating factor in mice

Leukemia. 2000 Apr;14(4):657-61. doi: 10.1038/sj.leu.2401735.

Abstract

Clinically detectable splenomegaly and splenic rupture are uncommon but potentially life-threatening consequences of G-CSF administration. Increased spleen size in mice injected with G-CSF is a complex genetic trait amenable to investigation in experimental inter-strain crosses by quantitative trait analysis. A quantitative trait locus (QTL) with highly significant linkage (LOD 7.9) for splenomegaly was identified within a 22 centimorgan (cM) region on chromosome 1. Inheritance of a C57BL/6 haplotype in this region was associated with a greater spleen weight. The relevance of this locus was confirmed by analysing the responses of mice congenic for the distal 12 cM of this region (C57BL/6 and C57BL/6.SJL-Ptprc(a) Pep3(b)). Consistent with the QTL effect, mice lacking C57BL/6 alleles in this region had reduced splenomegaly induced by G-CSF. Intriguingly, peripheral blood neutrophilia and progenitor cell mobilisation responses to G-CSF were also significantly influenced.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Chromosome Mapping
  • Crosses, Genetic
  • Female
  • Genetic Predisposition to Disease
  • Granulocyte Colony-Stimulating Factor / toxicity*
  • Hematopoietic Stem Cell Mobilization
  • Humans
  • Lenograstim
  • Lod Score
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred DBA
  • Organ Size
  • Quantitative Trait, Heritable
  • Recombinant Proteins / toxicity
  • Specific Pathogen-Free Organisms
  • Spleen / pathology
  • Splenomegaly / chemically induced
  • Splenomegaly / genetics*
  • Splenomegaly / pathology

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Lenograstim